Generated by All in One SEO v4.9.9, this is an llms.txt file, used by LLMs to index the site.

# ACT

Accelerating clinical trials for patients

## Sitemaps

- [XML Sitemap](https://www.act4patients.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [MyeCare Registry to improve standards of care and outcomes for Acute Myeloid Leukaemia (AML) patients](https://www.act4patients.com/myecare-registry/) - A collaboration between haematology specialists, Accelerating Clinical Trials Ltd (ACT) and Dendrite Clinical Systems, has resulted in the roll-out of the ‘MyeCare’ UK Acute Myeloid Leukaemia (AML) Registry. MyeCare Registry to improve standards of care and outcomes for Acute Myeloid Leukaemia (AML) patients A collaboration between haematology specialists, Accelerating Clinical Trials Ltd (ACT) and Dendrite
- [Let's talk Blood Cancer Podcast](https://www.act4patients.com/lets-talk-blood-cancer-podcast/) - If you do one thing today then please listen to the following podcast. Let’s talk Blood Cancer Podcast If you do one thing today then please listen to the following podcast. Let’s talk Blood Cancer Podcast If you do one thing today then please listen to the following podcast – Let’s Talk Blood Cancer, The
- [Elisabeth Kueenburg](https://www.act4patients.com/elisabeth-kueenburg/) - "I want to thank the whole ACT and IMPACT network for your great collaboration throughout the time we were working together. There was much support and many good communications, as mentioned to many of you I always perceived the communication with all of you as outstanding. Thank you for everything! We were honoured that we
- [A Night To Remember In The History Of ACT](https://www.act4patients.com/a-night-to-remember-in-the-history-of-act/) - The evening of the 1st of October marked a special occasion in the history of Accelerating Clinical Trials Ltd (ACT). A Night To Remember In The History Of ACT The evening of the 1st of October marked a special occasion in the history of Accelerating Clinical Trials Ltd (ACT). A Night To Remember In The
- [Prof Paresh Vyas](https://www.act4patients.com/prof-paresh-vyas/) - "At a time of rapid therapeutic innovation in blood cancers, new trial delivery models such as ACT are urgently needed. I am impressed with ACT's delivery to work with world class laboratories to deliver a truly transformative clinical trials proposition at pace" Prof Paresh Vyas Professor of Haematology at Oxford University
- [Prof Graham Jackson](https://www.act4patients.com/prof-graham-jackson/) - “ACT’s innovative structure and ability to accelerate the delivery of practice informing trials in conjunction with the UK haematology-oncology community will be of real benefit to blood cancer patients for whom new and more effective therapies are so urgently needed" Prof Graham Jackson Consultant Haematologist at Newcastle Hospitals NHS Foundation Trust
- [Dr Kate Cwynarski](https://www.act4patients.com/dr-kate-cwynarski/) - "There has never been a greater need for clinical trials of new therapies in lymphoma. I am therefore delighted that ACT’s commitment to fund the TAP and IMPACT networks will increase trial capacity in the UK and at the same time permit the delivery of registration enabling trials by UK clinicians. Our patients will benefit
- [Lord O’Shaughnessy’s landmark report](https://www.act4patients.com/lord-oshaughnessys-landmark-report/) - We welcome Lord O’Shaughnessy’s landmark report highlighting the importance of developing innovative models if the UK is to maintain global leadership in clinical trial delivery. Global leadership in clinical trial delivery We welcome Lord O’Shaughnessy’s landmark report highlighting the importance of developing innovative models if the UK is to maintain global leadership in clinical trial
- [ACT welcomes financial support from Anthony Nolan](https://www.act4patients.com/act-welcomes-financial-support-from-anthony-nolan/) - With support from Cure Leukaemia and NHSBT, ACT has been established as a commercial clinical trials delivery organisation with the aim of developing new treatments for blood cancers in the UK. ACT works with two networks of established and successful trial centres across the UK known as TAP and IMPACT. ACT welcomes financial support from
- [Accelerating Clinical Trials Ltd Appoints New CEO](https://www.act4patients.com/accelerating-clinical-trials-appoints-new-ceo/) - Accelerating Clinical Trials Ltd Appoints New CEO Accelerating Clinical Trials Ltd Appoints New CEO Accelerating Clinical Trials Ltd (ACT), a pioneer in accelerated clinical trial delivery, is delighted to announce the appointment of Dr Paul Sherrington as its new Chief Executive Officer. Accelerating Clinical Trials Ltd Appoints New CEO Accelerating Clinical Trials Ltd (ACT), a
- [ACT to Attend ASH 2024: Advancing Blood Cancer Research Together](https://www.act4patients.com/act-to-attend-ash-2024/) - ACT to Attend ASH 2024: Advancing Blood Cancer Research Together ACT to Attend ASH 2024: Advancing Blood Cancer Research Together We are excited to announce our attendance at the 2024 ASH Annual Meeting in San Diego ACT to Attend ASH 2024: Advancing Blood Cancer Research Together Accelerating Clinical Trials Ltd (ACT) is excited to announce

## Pages

- [Home](https://www.act4patients.com/) - A specialised trials delivery organisation dedicated to blood cancers, working hand-in-hand with the UK haematology community.
- [Senior Leadership Team](https://www.act4patients.com/senior-leadership-team/) - The Senior Leadership Team Meet our Senior Leadership Team: a solution-driven team of experienced clinical research professionals recruited from the pharmaceutical, CRO and academic sector who are all driven by a mission to improve outcomes for patients with blood cancers. Prof. Charles Craddock Medical Director Dr Paul Sherrington Chief Executive Officer Alicia Velascoin Commercial Operations
- [Careers](https://www.act4patients.com/careers/) - Careers Here at ACT, we are proud to be part of a close working team united by a desire to make a difference. We want to make a difference for patients affected by blood cancers, we want to make a difference by running research effectively and we want to make a difference by attracting important
- [Privacy Policy](https://www.act4patients.com/privacy-policy/) - Privacy Policy Accelerating Clinical Trials Ltd (ACT) is a Clinical Research Organisation specialising in blood cancer studies. We are registered with the Information Commissioners Office as a Data Controller, registration number ZB505572. Accelerating Clinical Trials Limited (“ACT”, “we”, “us”, “our”) is the data controller responsible for the personal data described in this Privacy Notice. Our
- [External Links and News](https://www.act4patients.com/external-link-and-news/) - External Links and News Here you can find links to sites and news reports relevant to blood cancer trials in the UK MyeCare Registry to improve standards of care and outcomes for Acute Myeloid Leukaemia (AML) patientsA collaboration between haematology specialists, Accelerating Clinical Trials Ltd (ACT) and Dendrite Clinical Systems, has…Let’s talk Blood Cancer PodcastIf
- [Our Networks](https://www.act4patients.com/our-networks/) - Our Network of Trial Sites Taken together the TAP and IMPACT networks have recruited more than 2,000 patients to practice informing drug and transplant studies led by UK investigators, resulting in high impact publications which have informed clinical practice worldwide. They play an important role in accelerating patient access to innovative therapies and incrementally improve
- [Directors](https://www.act4patients.com/directors/) - Our Directors Meet our highly engaged Board of Directors who have extensive commercial, pharmaceutical, academic haematology and trials experience and provide additional invaluable expertise. Charles De Rohan Chair Charles De Rohan Charles Craddock Gail Miflin Geoff Cousins Nicola Horlick Pam Bacon Graham Silk Mercia Page Paul Sherrington
- [About Us](https://www.act4patients.com/about-us/) - About Us New drug, transplant and cellular therapy trials are transforming the outcomes of patients with haematological malignancies. ACT was established to provide a sustainable infrastructure for conducting and accelerating specialised haemato-oncology trials in the UK, with diverse minds driving change. Our areas of focus We aspire to maximise the benefit of our portfolio of
- [Our Funders](https://www.act4patients.com/our-funders/) - Our Funders ACT is proud to be supported by key funders, including Cure Leukaemia, Anthony Nolan, and NHS Blood and Transplant (NHSBT), who play a vital role in advancing research and improving patient outcomes. Cure Leukaemia Cure Leukaemia is a UK-based charity dedicated to funding and supporting clinical research into leukaemia and other blood cancers.
- [Privacy Policy](https://www.act4patients.com/privacy-policy-3/) - Cookie Policy This cookie policy has been created and updated by Cookie Consent | CookieFirst. This cookie table has been created and updated by the Cookie Scanner.
- [Key Partners](https://www.act4patients.com/key-partners/) - Key Partners DIDACT Foundation (DF) is a registered charity that was founded by senior academic haematologists in order to optimise the delivery of UK blood cancer trials. DIDACT Foundation works closely, but not exclusively, with ACT. It engages with members of the academic haematology community and other relevant stakeholders like the blood cancer charities, patients
- [Mission](https://www.act4patients.com/mission/) - Mission Statement To accelerate haemato-oncology patient access to novel therapies, combinations and cellular therapies, and improve outcomes for patients. To attract, support and deliver research trials in the UK for patients with blood cancer. Vision Create a sustainable infrastructure to run haemato-oncology trials in the UK giving patients access to novel drug, stem cell transplant
- [Our Services](https://www.act4patients.com/our-services/) - Our Services TBC TBC TBC
- [404](https://www.act4patients.com/404-2/) - 404 Unfortunately the page you are looking for cannot be found. Back to homepage

## Categories

- [Testimonials](https://www.act4patients.com/category/testimonials/)
- [News](https://www.act4patients.com/category/news/)

## Tags

- [LEADERSHIP](https://www.act4patients.com/tag/leadership/)
- [INNOVATION](https://www.act4patients.com/tag/innovation/)